Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Porin A-specific antibody avidity in patients who are convalescing from meningococcal B disease.

Pediatric research - 1 Jul 2005

Vermont Clementien L, van Dijken Harry H, de Groot Ronald, van den Dobbelsteen Germie P J M

Abstract excerpt

Porin A (PorA), which determines the serosubtype of Neisseria meningitidis, is the main antigen of a candidate vaccine against serogroup B meningococci, which has been shown to induce high-avidity antibodies in children. We characterized the immune response of children after convalescing from meningococcal infection with a serosubtype P1.7-2,4 strain. Acute- and convalescent-phase sera of 21 children with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibody Affinity
Share to Enzyme-Linked Immunosorbent Assay

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Immunoglobulin G

Share to Meningococcal Infections

Share to Meningococcal Vaccines

Share to Neisseria meningitidis, Serogroup B

Share to Porins

Share to Sepsis

Source

Identifiers

PMID: 15774845
DOI: 10.1203/01.PDR.0000156372.13569.08

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Porin A-specific antibody avidity in patients who are convalescing from meningococcal B disease.PMID 15774845Read ↗

OpcA and PorB are novel bactericidal antigens of the 4CMenB vaccine in mice and humansSemantic proximity Read ↗

Review of Meningococcal Group B VaccinesSemantic proximity Read ↗

Human protective response induced by meningococcus B vaccine is mediated by the synergy of multiple bactericidal epitopesSemantic proximity Read ↗

Serum Bactericidal Antibody Responses of Adults Immunized with the MenB-4C Vaccine against Genetically Diverse Serogroup B Meningococci.Semantic proximity Read ↗

The Development of a Vaccine Against Meningococcus B Using Reverse VaccinologySemantic proximity Read ↗

A novel meningococcal outer membrane vesicle vaccine with constitutive expression of FetA: A phase I clinical trialSemantic proximity Read ↗

Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines.Semantic proximity Read ↗

Protective Antibody Responses Elicited by a Meningococcal Outer Membrane Vesicle Vaccine with Overexpressed Genome‐Derived Neisserial Antigen 1870Semantic proximity Read ↗

Activity of Human IgG and IgA Subclasses in Immune Defense Against Neisseria meningitidis Serogroup BSemantic proximity Read ↗

Meningococcal Outer Membrane Vesicle Vaccines Derived from Mutant Strains Engineered To Express Factor H Binding Proteins from Antigenic Variant Groups 1 and 2Semantic proximity Read ↗

FetA Antibodies Induced by an Outer Membrane Vesicle Vaccine Derived from a Serogroup B Meningococcal Isolate with Constitutive FetA Expression.Semantic proximity Read ↗

Meningococcal serogroup B vaccines: Estimating breadth of coverageSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.